CONJULITE Trademark

Trademark Overview

On Tuesday, June 9, 1998, a trademark application was filed for CONJULITE with the United States Patent and Trademark Office. The USPTO has given the CONJULITE trademark a serial number of 75499259. The federal status of this trademark filing is REGISTERED AND RENEWED as of Thursday, September 2, 2021. This trademark is owned by SOFTGEL TECHNOLOGIES, INC.. The CONJULITE trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceuticals, namely, nutritional supplements
conjulite

General Information

Serial Number75499259
Word MarkCONJULITE
Filing DateTuesday, June 9, 1998
Status800 - REGISTERED AND RENEWED
Status DateThursday, September 2, 2021
Registration Number2485580
Registration DateTuesday, September 4, 2001
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, May 4, 1999

Trademark Statements

Goods and Servicespharmaceuticals, namely, nutritional supplements

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, July 22, 1998
Primary Code005
First Use Anywhere DateThursday, January 18, 2001
First Use In Commerce DateThursday, January 18, 2001

Trademark Owner History

Party NameSOFTGEL TECHNOLOGIES, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressLos Angeles, CA 90040
Party NameSOFTGEL TECHNOLOGIES, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLos Angeles, CA 90040
Party NameSOFTGEL TECHNOLOGIES, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLos Angeles, CA 90040

Trademark Events

Event DateEvent Description
Thursday, September 2, 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Thursday, September 2, 2021REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
Thursday, September 2, 2021REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Wednesday, September 1, 2021TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Thursday, April 15, 2021POST REGISTRATION ACTION MAILED - SEC. 8 & 9
Wednesday, April 14, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, December 31, 2020TEAS SECTION 8 & 9 RECEIVED
Friday, September 4, 2020COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Thursday, February 2, 2012TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, December 14, 2011REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Wednesday, December 14, 2011REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Monday, December 12, 2011TEAS SECTION 8 & 9 RECEIVED
Thursday, September 6, 2007REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, August 31, 2007ASSIGNED TO PARALEGAL
Wednesday, August 15, 2007REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Wednesday, August 15, 2007TEAS SECTION 8 & 15 RECEIVED
Thursday, February 1, 2007CASE FILE IN TICRS
Monday, October 9, 2006TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, April 17, 2003TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 4, 2001REGISTERED-PRINCIPAL REGISTER
Thursday, March 22, 2001ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, March 13, 2001ASSIGNED TO EXAMINER
Wednesday, March 7, 2001STATEMENT OF USE PROCESSING COMPLETE
Wednesday, January 24, 2001USE AMENDMENT FILED
Tuesday, September 26, 2000EXTENSION 2 GRANTED
Thursday, July 27, 2000EXTENSION 2 FILED
Wednesday, January 26, 2000EXTENSION 1 GRANTED
Wednesday, January 26, 2000EXTENSION 1 FILED
Tuesday, July 27, 1999NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 4, 1999PUBLISHED FOR OPPOSITION
Friday, April 2, 1999NOTICE OF PUBLICATION
Tuesday, February 16, 1999APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, February 12, 1999ASSIGNED TO EXAMINER

Related Keywords

conjulite supplements nutritional namely pharmaceuticals